Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Finasteride lowers PSA levels in men, certain factors increase testicular cancer risk, and current guidelines for penile cancer may lead to unnecessary surgeries.

Lung cancer biology differs between women and men, with women responding better to certain treatments.

Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.

The cancer gene c-Myc increases harmful chemicals that damage DNA and can lead to cancer, but antioxidants can reduce this damage.

Pancreatic cancer had a very low survival rate and was hard to treat effectively.

Prostate cancer screening doesn't significantly reduce death rates and has risks like overdiagnosis and side effects.

The document suggests a possible link between hair loss and thyroid cancer, but doesn't provide definite proof.

Early baldness increases prostate cancer risk, radiotherapy and surgery have similar second cancer rates, and ALA may reduce prostate cancer risk.

Hair loss at the top of the head is linked to prostate cancer, but other types of hair loss are not.

Notch signalling helps skin cells differentiate and prevents tumors.

Prostate cancer was a major health issue in 2009, especially for Black men, and targeting the 5alpha-reductase enzyme could help in its prevention and treatment.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

New curcumin analogues help fight prostate cancer by breaking down androgen receptors.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.

Keratin 10 end domains may increase skin cancer risk by reducing cell death.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.